ES8501232A1 - Procedimiento para producir una formulacion topica estabilizada de acido seudomonico. - Google Patents

Procedimiento para producir una formulacion topica estabilizada de acido seudomonico.

Info

Publication number: ES8501232A1
Authority: ES; Spain
Prior art keywords: pref; peg; formulation; deriv; esp
Prior art date: 1982-05-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

ES522677A

Other languages

English (en)

Spanish (es)

Other versions

ES522677A0 (es

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Beecham Group PLC

Original Assignee

Beecham Group PLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-05-28

Filing date

1983-05-24

Publication date

1984-12-01

1983-05-24 Application filed by Beecham Group PLC filed Critical Beecham Group PLC

1984-12-01 Publication of ES522677A0 publication Critical patent/ES522677A0/es

1984-12-01 Publication of ES8501232A1 publication Critical patent/ES8501232A1/es

Status Expired legal-status Critical Current

Links

239000003814 drug Substances 0.000 title abstract 2
229940079593 drug Drugs 0.000 title 1
150000002148 esters Chemical class 0.000 abstract 3
150000003839 salts Chemical class 0.000 abstract 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
239000002202 Polyethylene glycol Substances 0.000 abstract 2
238000009472 formulation Methods 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
229920001223 polyethylene glycol Polymers 0.000 abstract 2
MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 abstract 1
CTPDSKVQLSDPLC-UHFFFAOYSA-N 2-(oxolan-2-ylmethoxy)ethanol Chemical compound OCCOCC1CCCO1 CTPDSKVQLSDPLC-UHFFFAOYSA-N 0.000 abstract 1
229920002565 Polyethylene Glycol 400 Polymers 0.000 abstract 1
229920001030 Polyethylene Glycol 4000 Polymers 0.000 abstract 1
229910052783 alkali metal Inorganic materials 0.000 abstract 1
-1 alkali metal salts Chemical class 0.000 abstract 1
125000005907 alkyl ester group Chemical group 0.000 abstract 1
125000002947 alkylene group Chemical group 0.000 abstract 1
239000003242 anti bacterial agent Substances 0.000 abstract 1
230000000844 anti-bacterial effect Effects 0.000 abstract 1
230000000843 anti-fungal effect Effects 0.000 abstract 1
239000002260 anti-inflammatory agent Substances 0.000 abstract 1
229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
230000000840 anti-viral effect Effects 0.000 abstract 1
239000003429 antifungal agent Substances 0.000 abstract 1
229940121375 antifungal agent Drugs 0.000 abstract 1
239000003443 antiviral agent Substances 0.000 abstract 1
230000003115 biocidal effect Effects 0.000 abstract 1
208000032625 disorder of ear Diseases 0.000 abstract 1
208000030533 eye disease Diseases 0.000 abstract 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
MINDHVHHQZYEEK-HBBNESRFSA-N mupirocin Chemical compound C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-HBBNESRFSA-N 0.000 abstract 1
229960003128 mupirocin Drugs 0.000 abstract 1
229930194369 pseudomonic acid Natural products 0.000 abstract 1
208000017520 skin disease Diseases 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1
239000012049 topical pharmaceutical composition Substances 0.000 abstract 1

Landscapes

Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ES522677A 1982-05-28 1983-05-24 Procedimiento para producir una formulacion topica estabilizada de acido seudomonico. Expired ES8501232A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB8215684		1982-05-28

Publications (2)

Publication Number	Publication Date
ES522677A0 ES522677A0 (es)	1984-12-01
ES8501232A1 true ES8501232A1 (es)	1984-12-01

Family

ID=10530708

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES522677A Expired ES8501232A1 (es)	1982-05-28	1983-05-24	Procedimiento para producir una formulacion topica estabilizada de acido seudomonico.

Country Status (3)

Country	Link
JP (1)	JPS58219108A (cs)
ES (1)	ES8501232A1 (cs)
ZA (1)	ZA833692B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN105555271A (zh) *	2013-09-20	2016-05-04	参天制药株式会社	含有聚乙二醇的组合物

1983
- 1983-05-23 ZA ZA833692A patent/ZA833692B/xx unknown
- 1983-05-24 JP JP9139083A patent/JPS58219108A/ja active Granted
- 1983-05-24 ES ES522677A patent/ES8501232A1/es not_active Expired

Also Published As

Publication number	Publication date
JPS58219108A (ja)	1983-12-20
ES522677A0 (es)	1984-12-01
ZA833692B (en)	1985-02-27
JPH0348886B2 (cs)	1991-07-25

Similar Documents

Publication	Publication Date	Title
IE831205L (en)	1983-11-28	Pharmaceutical formulations.
UA41906C2 (uk)	2001-10-15	Спосіб лікування неврологічних порушень, викликаних травмами
AU549481B2 (en)	1986-01-30	Hair growing agent
NL950022I2 (nl)	1996-12-02	Analoga van mevalolacton en derivaten daarvan, werkwijzen voor hun bereiding, farmaceutische prepar aten die ze bevatten en hun toepassing als farmaceutica.
EP0285008A3 (en)	1990-06-06	The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
YU209288A (en)	1990-04-30	Process for producing compound for treating, which contains azelastin for use in nose and/or eye
CA2125662A1 (en)	1993-07-08	Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
ES8700850A1 (es)	1986-11-16	1,4-dihidropiridin-carboxiamidas.
MY104006A (en)	1993-10-30	4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases.
FR2432520A1 (fr)	1980-02-29	Nouvelles imidazoquinoxalines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
ES8501232A1 (es)	1984-12-01	Procedimiento para producir una formulacion topica estabilizada de acido seudomonico.
EP0500953A4 (en)	1993-04-21	Antineoplastic effect potentiator and antineoplastic agent
CA2038025A1 (en)	1991-09-15	Optically active alkylenedioxybenzene derivatives and their use in therapy
IE832787L (en)	1984-05-29	Polyether compounds.
GR78622B (cs)	1984-09-27
EP0471388A3 (de)	1992-03-11	Mittel zur Behandlung der Herzinsuffizienz
TW258733B (cs)	1995-10-01
GR81464B (cs)	1984-12-11
DE3168004D1 (en)	1985-02-14	Ophthalmic composition of 5-fluoro-2-methyl-1-(p-methylthio-benzylidene)-3-indenylacetic acid or salt thereof
EP0294814A3 (en)	1990-09-19	Treating agents for renal diseases
SE8303400D0 (sv)	1983-06-15	Azo-bis-salicylsyra och salt derav samt deras farmaceutiska beredning och anvendning
IT7945204A0 (it)	1979-03-05	Composizione farmaceutica per la terapia delle sterilita' maschile
MY110416A (en)	1998-05-30	Composition for the treatment of schizophrenia.